ADCY3 and obesity due to melanocortin 4 receptor deficiency: Taken together, these findings suggest that the nonsense variant leads to a loss of ADCY3 function, which in turn impairs enzymatic activity and contributes to the development of obesity, consistent with the patient’s phenotype.